Skip to main content
Erschienen in: World Journal of Surgery 9/2011

01.09.2011

Risk Factors Influencing Postoperative Outcomes of Major Hepatic Resection of Hepatocellular Carcinoma for Patients with Underlying Liver Diseases

verfasst von: Tian Yang, Jin Zhang, Jun-Hua Lu, Guang-Shun Yang, Meng-Chao Wu, Wei-Feng Yu

Erschienen in: World Journal of Surgery | Ausgabe 9/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Major hepatic resection of more than three segments in patients with hepatocellular carcinoma (HCC) is a high-risk operation, especially in patients with co-existing underlying liver diseases. The present study evaluated risk factors for postoperative morbidity and mortality after major hepatic resection in HCC patients with underlying liver diseases.

Methods

Perioperative data of 305 HCC patients with underlying liver diseases who underwent major hepatic resection were evaluated by univariate and multivariate analyses to identify risk factors for postoperative morbidity and mortality.

Results

The overall morbidity rate was 37.0% (n = 113), caused by pleural effusion (n = 56), ascites (n = 43), subphrenic effusion/infection (n = 23), hepatic dysfunction (n = 22), bile leakage (n = 10), respiratory infection (n = 7), incision infection (n = 7), intra-abdominal hemorrhage (n = 5), and others. The hospital mortality rate was 2.6% (n = 8), primarily caused by liver failure (4/8). Multivariate logistic regression analysis showed that preoperative platelet count <100 × 109/l (P = 0.006), and increased intraoperative blood loss (≥800 ml) (P = 0.008) were independent risk factors of postoperative morbidity, and that preoperative prothrombin time >14 s (P = 0.015) and preoperative platelet count <100 × 109/l (P = 0.007) were independent risk factors for significant hospital mortality.

Conclusions

Careful preoperative selection of patients in terms of the Child-Pugh classification and decrease of intraoperative blood loss are important measures to reduce postoperative morbidity after major hepatic resection in HCC patients with underlying liver diseases. Moreover, we should be aware that preoperative platelet count is independently associated with postoperative morbidity and mortality for those patients following major hepatic resection.
Literatur
1.
Zurück zum Zitat Fan ST, Lo CM, Liu CL et al (1999) Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 229:322–330PubMedCrossRef Fan ST, Lo CM, Liu CL et al (1999) Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 229:322–330PubMedCrossRef
2.
Zurück zum Zitat Cescon M, Vetrone G, Grazi GL et al (2009) Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. Ann Surg 249:995–1002PubMedCrossRef Cescon M, Vetrone G, Grazi GL et al (2009) Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. Ann Surg 249:995–1002PubMedCrossRef
3.
Zurück zum Zitat Zhou L, Rui JA, Wang SB et al (2007) Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy. World J Surg 31:1782–1787PubMedCrossRef Zhou L, Rui JA, Wang SB et al (2007) Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy. World J Surg 31:1782–1787PubMedCrossRef
4.
Zurück zum Zitat Mizuguchi T, Katsuramaki T, Nagayama M et al (2008) Rapid recovery of postoperative liver function after major hepatectomy using saline-linked electric cautery. Hepatogastroenterology 55:2188–2192PubMed Mizuguchi T, Katsuramaki T, Nagayama M et al (2008) Rapid recovery of postoperative liver function after major hepatectomy using saline-linked electric cautery. Hepatogastroenterology 55:2188–2192PubMed
5.
Zurück zum Zitat Poon RT, Fan ST, Lo CM et al (2001) Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 234:63–70PubMedCrossRef Poon RT, Fan ST, Lo CM et al (2001) Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 234:63–70PubMedCrossRef
6.
Zurück zum Zitat Taketomi A, Kitagawa D, Itoh S et al (2007) Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute’s experience with 625 patients. J Am Coll Surg 204:580–587PubMedCrossRef Taketomi A, Kitagawa D, Itoh S et al (2007) Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute’s experience with 625 patients. J Am Coll Surg 204:580–587PubMedCrossRef
7.
Zurück zum Zitat International Hepato Pancreato Biliary Association (2002) The Brisbane 2000 terminology of liver anatomy and resections. HPB 2:333–339; HPB (Oxford) 4:99–100 International Hepato Pancreato Biliary Association (2002) The Brisbane 2000 terminology of liver anatomy and resections. HPB 2:333–339; HPB (Oxford) 4:99–100
8.
Zurück zum Zitat Teh SH, Christein J, Donohue J et al (2005) Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: model of end-stage liver disease (MELD) score predicts perioperative mortality. J Gastrointest Surg 9:1207–1215; discussion 1215PubMedCrossRef Teh SH, Christein J, Donohue J et al (2005) Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: model of end-stage liver disease (MELD) score predicts perioperative mortality. J Gastrointest Surg 9:1207–1215; discussion 1215PubMedCrossRef
9.
Zurück zum Zitat Fan ST, Lai EC, Lo CM et al (1995) Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg 130:198–203PubMed Fan ST, Lai EC, Lo CM et al (1995) Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg 130:198–203PubMed
10.
11.
Zurück zum Zitat Fortner JG, Kim DK, Maclean BJ et al (1978) Major hepatic resection for neoplasia: personal experience in 108 patients. Ann Surg 188:363–371PubMedCrossRef Fortner JG, Kim DK, Maclean BJ et al (1978) Major hepatic resection for neoplasia: personal experience in 108 patients. Ann Surg 188:363–371PubMedCrossRef
12.
Zurück zum Zitat Thompson HH, Tompkins RK, Longmire WP Jr (1983) Major hepatic resection. A 25-year experience. Ann Surg 197:375–388PubMedCrossRef Thompson HH, Tompkins RK, Longmire WP Jr (1983) Major hepatic resection. A 25-year experience. Ann Surg 197:375–388PubMedCrossRef
13.
Zurück zum Zitat Farges O, Malassagne B, Flejou JF et al (1999) Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg 229:210–215PubMedCrossRef Farges O, Malassagne B, Flejou JF et al (1999) Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg 229:210–215PubMedCrossRef
14.
Zurück zum Zitat Poon RT, Fan ST, Lo CM et al (2002) Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified. Ann Surg 236:602–611PubMedCrossRef Poon RT, Fan ST, Lo CM et al (2002) Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified. Ann Surg 236:602–611PubMedCrossRef
15.
Zurück zum Zitat Capussotti L, Borgonovo G, Bouzari H et al (1994) Results of major hepatectomy for large primary liver cancer in patients with cirrhosis. Br J Surg 81:427–431PubMedCrossRef Capussotti L, Borgonovo G, Bouzari H et al (1994) Results of major hepatectomy for large primary liver cancer in patients with cirrhosis. Br J Surg 81:427–431PubMedCrossRef
16.
Zurück zum Zitat Yang T, Zhang J, Lu JH et al (2011) A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort. J Cancer Res Clin Oncol 137:739–750PubMedCrossRef Yang T, Zhang J, Lu JH et al (2011) A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort. J Cancer Res Clin Oncol 137:739–750PubMedCrossRef
17.
Zurück zum Zitat Chiappa A, Zbar AP, Audisio RA et al (2000) Factors affecting survival and long-term outcome in the cirrhotic patient undergoing hepatic resection for hepatocellular carcinoma. Eur J Surg Oncol 26:387–392PubMedCrossRef Chiappa A, Zbar AP, Audisio RA et al (2000) Factors affecting survival and long-term outcome in the cirrhotic patient undergoing hepatic resection for hepatocellular carcinoma. Eur J Surg Oncol 26:387–392PubMedCrossRef
18.
Zurück zum Zitat Imamura H, Seyama Y, Kokudo N et al (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138:1198–1206; discussion 1206PubMedCrossRef Imamura H, Seyama Y, Kokudo N et al (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138:1198–1206; discussion 1206PubMedCrossRef
19.
Zurück zum Zitat Benzoni E, Molaro R, Cedolini C et al (2007) Liver resection for HCC: analysis of causes and risk factors linked to postoperative complications. Hepatogastroenterology 54:186–189PubMed Benzoni E, Molaro R, Cedolini C et al (2007) Liver resection for HCC: analysis of causes and risk factors linked to postoperative complications. Hepatogastroenterology 54:186–189PubMed
20.
Zurück zum Zitat Nagasue N, Kohno H, Chang YC et al (1993) Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg 217:375–384PubMedCrossRef Nagasue N, Kohno H, Chang YC et al (1993) Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg 217:375–384PubMedCrossRef
21.
Zurück zum Zitat Wei AC, Tung-Ping PR, Fan ST et al (2003) Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg 90:33–41PubMedCrossRef Wei AC, Tung-Ping PR, Fan ST et al (2003) Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg 90:33–41PubMedCrossRef
22.
Zurück zum Zitat Shimada M, Takenaka K, Fujiwara Y et al (1998) Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma. Br J Surg 85:195–198PubMedCrossRef Shimada M, Takenaka K, Fujiwara Y et al (1998) Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma. Br J Surg 85:195–198PubMedCrossRef
23.
Zurück zum Zitat Torzilli G, Makuuchi M, Inoue K et al (1999) No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 134:984–992PubMedCrossRef Torzilli G, Makuuchi M, Inoue K et al (1999) No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 134:984–992PubMedCrossRef
24.
Zurück zum Zitat Itamoto T, Nakahara H, Amano H et al (2007) Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery 141:589–597PubMedCrossRef Itamoto T, Nakahara H, Amano H et al (2007) Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery 141:589–597PubMedCrossRef
25.
Zurück zum Zitat Tung-Ping PR, Fan ST, Wong J (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232:10–24CrossRef Tung-Ping PR, Fan ST, Wong J (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232:10–24CrossRef
26.
Zurück zum Zitat Minagawa M, Makuuchi M, Takayama T et al (2003) Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 238:703–710PubMedCrossRef Minagawa M, Makuuchi M, Takayama T et al (2003) Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 238:703–710PubMedCrossRef
27.
Zurück zum Zitat Salem RR (2002) Recurrent hepatocellular carcinoma: to resect or not to resect. J Clin Gastroenterol 35:S147–S151PubMedCrossRef Salem RR (2002) Recurrent hepatocellular carcinoma: to resect or not to resect. J Clin Gastroenterol 35:S147–S151PubMedCrossRef
28.
Zurück zum Zitat Bruix J, Castells A, Bosch J et al (1996) Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111:1018–1022PubMedCrossRef Bruix J, Castells A, Bosch J et al (1996) Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111:1018–1022PubMedCrossRef
29.
Zurück zum Zitat Murata S, Ohkohchi N, Matsuo R et al (2007) Platelets promote liver regeneration in early period after hepatectomy in mice. World J Surg 31:808–816PubMedCrossRef Murata S, Ohkohchi N, Matsuo R et al (2007) Platelets promote liver regeneration in early period after hepatectomy in mice. World J Surg 31:808–816PubMedCrossRef
30.
Zurück zum Zitat Myronovych A, Murata S, Chiba M et al (2008) Role of platelets on liver regeneration after 90% hepatectomy in mice. J Hepatol 49:363–372PubMedCrossRef Myronovych A, Murata S, Chiba M et al (2008) Role of platelets on liver regeneration after 90% hepatectomy in mice. J Hepatol 49:363–372PubMedCrossRef
31.
Zurück zum Zitat Murata S, Matsuo R, Ikeda O et al (2008) Platelets promote liver regeneration under conditions of Kupffer cell depletion after hepatectomy in mice. World J Surg 32:1088–1096PubMedCrossRef Murata S, Matsuo R, Ikeda O et al (2008) Platelets promote liver regeneration under conditions of Kupffer cell depletion after hepatectomy in mice. World J Surg 32:1088–1096PubMedCrossRef
32.
Zurück zum Zitat Watanabe M, Murata S, Hashimoto I et al (2009) Platelets contribute to the reduction of liver fibrosis in mice. J Gastroenterol Hepatol 24:78–89PubMedCrossRef Watanabe M, Murata S, Hashimoto I et al (2009) Platelets contribute to the reduction of liver fibrosis in mice. J Gastroenterol Hepatol 24:78–89PubMedCrossRef
33.
Zurück zum Zitat Matsuo R, Ohkohchi N, Murata S et al (2008) Platelets strongly induce hepatocyte proliferation with IGF-1 and HGF in vitro. J Surg Res 145:279–286PubMedCrossRef Matsuo R, Ohkohchi N, Murata S et al (2008) Platelets strongly induce hepatocyte proliferation with IGF-1 and HGF in vitro. J Surg Res 145:279–286PubMedCrossRef
34.
Zurück zum Zitat Ishizawa T, Hasegawa K, Kokudo N et al (2009) Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg 144:46–51PubMedCrossRef Ishizawa T, Hasegawa K, Kokudo N et al (2009) Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg 144:46–51PubMedCrossRef
35.
Zurück zum Zitat Capussotti L, Muratore A, Amisano M et al (2005) Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival–a European single center experience. Eur J Surg Oncol 31:986–993PubMedCrossRef Capussotti L, Muratore A, Amisano M et al (2005) Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival–a European single center experience. Eur J Surg Oncol 31:986–993PubMedCrossRef
36.
Zurück zum Zitat Ishizaki Y, Yoshimoto J, Miwa K et al (2006) Safety of prolonged intermittent Pringle maneuver during hepatic resection. Arch Surg 141:649–653; discussion 654PubMedCrossRef Ishizaki Y, Yoshimoto J, Miwa K et al (2006) Safety of prolonged intermittent Pringle maneuver during hepatic resection. Arch Surg 141:649–653; discussion 654PubMedCrossRef
37.
Zurück zum Zitat Emond J, Wachs ME, Renz JF et al (1995) Total vascular exclusion for major hepatectomy in patients with abnormal liver parenchyma. Arch Surg 130:824–830; discussion 830–831PubMed Emond J, Wachs ME, Renz JF et al (1995) Total vascular exclusion for major hepatectomy in patients with abnormal liver parenchyma. Arch Surg 130:824–830; discussion 830–831PubMed
38.
Zurück zum Zitat Sakamoto Y, Yamamoto J, Kokudo N et al (2004) Bloodless liver resection using the monopolar floating ball plus ligasure diathermy: preliminary results of 16 liver resections. World J Surg 28:166–172PubMedCrossRef Sakamoto Y, Yamamoto J, Kokudo N et al (2004) Bloodless liver resection using the monopolar floating ball plus ligasure diathermy: preliminary results of 16 liver resections. World J Surg 28:166–172PubMedCrossRef
39.
Zurück zum Zitat Kim SH, Park SJ, Lee SA et al (2007) Various liver resections using hanging maneuver by three Glisson’s pedicles and three hepatic veins. Ann Surg 245:201–205PubMedCrossRef Kim SH, Park SJ, Lee SA et al (2007) Various liver resections using hanging maneuver by three Glisson’s pedicles and three hepatic veins. Ann Surg 245:201–205PubMedCrossRef
Metadaten
Titel
Risk Factors Influencing Postoperative Outcomes of Major Hepatic Resection of Hepatocellular Carcinoma for Patients with Underlying Liver Diseases
verfasst von
Tian Yang
Jin Zhang
Jun-Hua Lu
Guang-Shun Yang
Meng-Chao Wu
Wei-Feng Yu
Publikationsdatum
01.09.2011
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 9/2011
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-011-1161-0

Weitere Artikel der Ausgabe 9/2011

World Journal of Surgery 9/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.